Literature DB >> 22525576

Initiation, evolution, phenotype and outcome of BRCA1 and BRCA2 mutation-associated breast cancer.

Ke-Da Yu, Zhi-Ming Shao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525576     DOI: 10.1038/nrc3181-c1

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  15 in total

1.  Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.

Authors:  Pamela J Goodwin; Kelly-Anne Phillips; Dee W West; Marguerite Ennis; John L Hopper; Esther M John; Frances P O'Malley; Roger L Milne; Irene L Andrulis; Michael L Friedlander; Melissa C Southey; Carmel Apicella; Graham G Giles; Teri A Longacre
Journal:  J Clin Oncol       Date:  2011-12-05       Impact factor: 44.544

2.  Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.

Authors:  Da Pang; Yashuang Zhao; Weinan Xue; Ming Shan; Yanbo Chen; Youxue Zhang; Guoqiang Zhang; Feng Liu; Dalin Li; Yanmei Yang
Journal:  Med Oncol       Date:  2011-11-11       Impact factor: 3.064

3.  Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.

Authors:  Kelly L Bolton; Georgia Chenevix-Trench; Cindy Goh; Siegal Sadetzki; Susan J Ramus; Beth Y Karlan; Diether Lambrechts; Evelyn Despierre; Daniel Barrowdale; Lesley McGuffog; Sue Healey; Douglas F Easton; Olga Sinilnikova; Javier Benítez; María J García; Susan Neuhausen; Mitchell H Gail; Patricia Hartge; Susan Peock; Debra Frost; D Gareth Evans; Rosalind Eeles; Andrew K Godwin; Mary B Daly; Ava Kwong; Edmond S K Ma; Conxi Lázaro; Ignacio Blanco; Marco Montagna; Emma D'Andrea; Maria Ornella Nicoletto; Sharon E Johnatty; Susanne Krüger Kjær; Allan Jensen; Estrid Høgdall; Ellen L Goode; Brooke L Fridley; Jennifer T Loud; Mark H Greene; Phuong L Mai; Angela Chetrit; Flora Lubin; Galit Hirsh-Yechezkel; Gord Glendon; Irene L Andrulis; Amanda E Toland; Leigha Senter; Martin E Gore; Charlie Gourley; Caroline O Michie; Honglin Song; Jonathan Tyrer; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Ulf Kristoffersson; Håkan Olsson; Åke Borg; Douglas A Levine; Linda Steele; Mary S Beattie; Salina Chan; Robert L Nussbaum; Kirsten B Moysich; Jenny Gross; Ilana Cass; Christine Walsh; Andrew J Li; Ronald Leuchter; Ora Gordon; Montserrat Garcia-Closas; Simon A Gayther; Stephen J Chanock; Antonis C Antoniou; Paul D P Pharoah
Journal:  JAMA       Date:  2012-01-25       Impact factor: 56.272

Review 4.  Estrogen carcinogenesis in breast cancer.

Authors:  James D Yager; Nancy E Davidson
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

Review 5.  Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis.

Authors:  Eun-Ha Lee; Sue K Park; Boyoung Park; Sung-Won Kim; Min Hyuk Lee; Sei Hyun Ahn; Byung Ho Son; Keun-Young Yoo; Daehee Kang
Journal:  Breast Cancer Res Treat       Date:  2010-04-08       Impact factor: 4.872

Review 6.  The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling.

Authors:  Gemma Molyneux; Matthew J Smalley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-02-19       Impact factor: 2.673

7.  Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.

Authors:  Tari A King; Weiwei Li; Edi Brogi; Cindy J Yee; Mary L Gemignani; Narciso Olvera; Douglas A Levine; Larry Norton; Mark E Robson; Kenneth Offit; Patrick I Borgen; Jeff Boyd
Journal:  Ann Surg Oncol       Date:  2007-06-29       Impact factor: 5.344

8.  BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer.

Authors:  Julia J Gorski; Colin R James; Jennifer E Quinn; Gail E Stewart; Kieran Crosbie Staunton; Niamh E Buckley; Fionnuala A McDyer; Richard D Kennedy; Richard H Wilson; Paul B Mullan; D Paul Harkin
Journal:  Breast Cancer Res Treat       Date:  2009-10-31       Impact factor: 4.872

9.  CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer.

Authors:  Olafur Andri Stefansson; Jon Gunnlaugur Jonasson; Kristrun Olafsdottir; Holmfridur Hilmarsdottir; Gudridur Olafsdottir; Manel Esteller; Oskar Thor Johannsson; Jorunn Erla Eyfjord
Journal:  Epigenetics       Date:  2011-05       Impact factor: 4.528

10.  Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

Authors:  Anna Marie Mulligan; Fergus J Couch; Daniel Barrowdale; Susan M Domchek; Diana Eccles; Heli Nevanlinna; Susan J Ramus; Mark Robson; Mark Sherman; Amanda B Spurdle; Barbara Wappenschmidt; Andrew Lee; Lesley McGuffog; Sue Healey; Olga M Sinilnikova; Ramunas Janavicius; Thomas vO Hansen; Finn C Nielsen; Bent Ejlertsen; Ana Osorio; Iván Muñoz-Repeto; Mercedes Durán; Javier Godino; Maroulio Pertesi; Javier Benítez; Paolo Peterlongo; Siranoush Manoukian; Bernard Peissel; Daniela Zaffaroni; Elisa Cattaneo; Bernardo Bonanni; Alessandra Viel; Barbara Pasini; Laura Papi; Laura Ottini; Antonella Savarese; Loris Bernard; Paolo Radice; Ute Hamann; Martijn Verheus; Hanne E J Meijers-Heijboer; Juul Wijnen; Encarna B Gómez García; Marcel R Nelen; C Marleen Kets; Caroline Seynaeve; Madeleine M A Tilanus-Linthorst; Rob B van der Luijt; Theo van Os; Matti Rookus; Debra Frost; J Louise Jones; D Gareth Evans; Fiona Lalloo; Ros Eeles; Louise Izatt; Julian Adlard; Rosemarie Davidson; Jackie Cook; Alan Donaldson; Huw Dorkins; Helen Gregory; Jacqueline Eason; Catherine Houghton; Julian Barwell; Lucy E Side; Emma McCann; Alex Murray; Susan Peock; Andrew K Godwin; Rita K Schmutzler; Kerstin Rhiem; Christoph Engel; Alfons Meindl; Ina Ruehl; Norbert Arnold; Dieter Niederacher; Christian Sutter; Helmut Deissler; Dorothea Gadzicki; Karin Kast; Sabine Preisler-Adams; Raymonda Varon-Mateeva; Ines Schoenbuchner; Britta Fiebig; Wolfram Heinritz; Dieter Schäfer; Heidrun Gevensleben; Virginie Caux-Moncoutier; Marion Fassy-Colcombet; François Cornelis; Sylvie Mazoyer; Mélanie Léoné; Nadia Boutry-Kryza; Agnès Hardouin; Pascaline Berthet; Danièle Muller; Jean-Pierre Fricker; Isabelle Mortemousque; Pascal Pujol; Isabelle Coupier; Marine Lebrun; Caroline Kientz; Michel Longy; Nicolas Sevenet; Dominique Stoppa-Lyonnet; Claudine Isaacs; Trinidad Caldes; Miguel de la Hoya; Tuomas Heikkinen; Kristiina Aittomäki; Ignacio Blanco; Conxi Lazaro; Rosa B Barkardottir; Penny Soucy; Martine Dumont; Jacques Simard; Marco Montagna; Silvia Tognazzo; Emma D'Andrea; Stephen Fox; Max Yan; Tim Rebbeck; Olufunmilayo Olopade; Jeffrey N Weitzel; Henry T Lynch; Patricia A Ganz; Gail E Tomlinson; Xianshu Wang; Zachary Fredericksen; Vernon S Pankratz; Noralane M Lindor; Csilla Szabo; Kenneth Offit; Rita Sakr; Mia Gaudet; Jasmine Bhatia; Noah Kauff; Christian F Singer; Muy-Kheng Tea; Daphne Gschwantler-Kaulich; Anneliese Fink-Retter; Phuong L Mai; Mark H Greene; Evgeny Imyanitov; Frances P O'Malley; Hilmi Ozcelik; Gordon Glendon; Amanda E Toland; Anne-Marie Gerdes; Mads Thomassen; Torben A Kruse; Uffe Birk Jensen; Anne-Bine Skytte; Maria A Caligo; Maria Soller; Karin Henriksson; von Anna Wachenfeldt; Brita Arver; Marie Stenmark-Askmalm; Per Karlsson; Yuan Chun Ding; Susan L Neuhausen; Mary Beattie; Paul D P Pharoah; Kirsten B Moysich; Katherine L Nathanson; Beth Y Karlan; Jenny Gross; Esther M John; Mary B Daly; Saundra M Buys; Melissa C Southey; John L Hopper; Mary Beth Terry; Wendy Chung; Alexander F Miron; David Goldgar; Georgia Chenevix-Trench; Douglas F Easton; Irene L Andrulis; Antonis C Antoniou
Journal:  Breast Cancer Res       Date:  2011-11-02       Impact factor: 6.466

View more
  1 in total

1.  A phylogenetic model for understanding the effect of gene duplication on cancer progression.

Authors:  Qin Ma; Jaxk H Reeves; David A Liberles; Lili Yu; Zheng Chang; Jing Zhao; Juan Cui; Ying Xu; Liang Liu
Journal:  Nucleic Acids Res       Date:  2013-12-25       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.